|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ettinger DS, Akerley W, Bepler G, Blum MG,
Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, et
al: Non-small cell lung cancer. J Natl Compr Canc Netw. 8:740–801.
2010.PubMed/NCBI
|
|
3
|
Crinò L, Weder W, van Meerbeeck J and
Felip E: ESMO Guidelines Working Group: Early stage and locally
advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21:(Suppl 5). v103–v115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Swensen SJ, Jett JR, Hartman TE, Midthun
DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO
and Allen KL: CT screening for lung cancer: five-year prospective
experience. Radiology. 235:259–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C,
Wang C, Ren Z, Zhao Y, Wu S, et al: Identification of ten serum
microRNAs from a genome-wide serum microRNA expression profile as
novel non-invasive biomarkers for nonsmall cell lung cancer
diagnosis. Int J Cancer. 130:1620–1628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Keller A, Leidinger P, Gislefoss R, Haugen
A, Langseth H, Staehler P, Lenhof HP and Meese E: Stable serum
miRNA profiles as potential tool for non-invasive lung cancer
diagnosis. RNA Biol. 8:506–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen J, Todd NW, Zhang H, Yu L, Lingxiao
X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, et al: Plasma
microRNAs as potential biomarkers for non-small-cell lung cancer.
Lab Invest. 91:579–587. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: a novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Silva J, Garcia V, Zaballos Á, Provencio
M, Lombardía L, Almonacid L, García JM, Domínguez G, Peña C, Diaz
R, et al: Vesicle-related microRNAs in plasma of nonsmall cell lung
cancer patients and correlation with survival. Eur Respir J.
37:617–623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsim S, O'Dowd CA, Milroy R and Davidson
S: Staging of non-small cell lung cancer (NSCLC): a review. Respir
Med. 104:1767–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW
and Lin SC: Increase of microRNA miR-31 level in plasma could be a
potential marker of oral cancer. Oral Dis. 16:360–364. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Russ R and Slack FJ:
Cigarette-smoke-induced dysregulation of MicroRNA expression and
its role in lung carcinogenesis. Pulm Med. 2012:7912342012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu X, Piper-Hunter MG, Crawford M, Nuovo
GJ, Marsh CB, Otterson GA and Nana-Sinkam SP: MicroRNAs in the
pathogenesis of lung cancer. J Thorac Oncol. 4:1028–1034. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swensen SJ, Jett JR, Sloan JA, Midthun DE,
Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel
GR, et al: Screening for lung cancer with low-dose spiral computed
tomography. Am J Respir Crit Care Med. 165:508–513. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wieskopf B, Demangeat C, Purohit A,
Stenger R, Gries P, Kreisman H and Quoix E: Cyfra 21-1 as a
biologic marker of non-small cell lung cancer. Evaluation of
sensitivity, specificity, and prognostic role. Chest. 108:163–169.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nisman B, Lafair J, Heching N, Lyass O,
Baras M, Peretz T and Barak V: Evaluation of tissue polypeptide
specific antigen, CYFRA 21-1, and carcinoembryonic antigen in
nonsmall cell lung carcinoma: does the combined use of cytokeratin
markers give any additional information? Cancer. 82:1850–1859.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Andersen M, Grauslund M, Ravn J, Sørensen
JB, Andersen CB and Santoni-Rugiu E: Diagnostic potential of
miR-126, miR-143, miR-145, and miR-652 in malignant pleural
mesothelioma. J Mol Diagn. 16:418–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng H, Zhang L, Zhao Y, Yang D, Song F,
Wen Y, Hao Q, Hu Z, Zhang W and Chen K: Plasma miRNAs as diagnostic
and prognostic biomarkers for ovarian cancer. PLoS One.
8:e778532013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang RJ, Zheng YH, Wang P and Zhang JZ:
Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in
non-small cell lung cancer. Int J Clin Exp Pathol. 8:765–771.
2015.PubMed/NCBI
|
|
30
|
Foss KM, Sima C, Ugolini D, Neri M, Allen
KE and Weiss GJ: miR-1254 and miR-574-5p: serum-based microRNA
biomarkers for early-stage non-small cell lung cancer. J Thorac
Oncol. 6:482–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Capodanno A, Boldrini L, Proietti A, Alì
G, Pelliccioni S, Niccoli C, D'Incecco A, Cappuzzo F, Chella A,
Lucchi M, et al: Let-7g and miR-21 expression in non-small cell
lung cancer: correlation with clinicopathological and molecular
features. Int J Oncol. 43:765–774. 2013.PubMed/NCBI
|
|
33
|
Yang M, Shen H, Qiu C, Ni Y, Wang L, Dong
W, Liao Y and Du J: High expression of miR-21 and miR-155 predicts
recurrence and unfavourable survival in non-small cell lung cancer.
Eur J Cancer. 49:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: miRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zou C, Xu Q, Mao F, Li D, Bian C, Liu LZ,
Jiang Y, Chen X, Qi Y, Zhang X, et al: MiR-145 inhibits tumor
angiogenesis and growth by N-RAS and VEGF. Cell Cycle.
11:2137–2145. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mar-Aguilar F, Mendoza-Ramirez JA,
Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK,
Ruiz-Flores P, Rodríguez-Padilla C and Reséndez-Pérez D: Serum
circulating microRNA profiling for identification of potential
breast cancer biomarkers. Dis Markers. 34:163–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma
ES, Pang R, Chua D, Chu KM, Law WL, et al: Circulating microRNAs as
specific biomarkers for breast cancer detection. PLoS One.
8:e531412013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Haneklaus M, Gerlic M, O'Neill LA and
Masters SL: miR-223: infection, inflammation and cancer. J Intern
Med. 274:215–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nian W, Ao X, Wu Y, Huang Y, Shao J, Wang
Y, Chen Z, Chen F and Wang D: miR-223 functions as a potent tumor
suppressor of the Lewis lung carcinoma cell line by targeting
insulin-like growth factor-1 receptor and cyclin-dependent kinase
2. Oncol Lett. 6:359–366. 2013.PubMed/NCBI
|
|
41
|
Lawrie CH, Gal S, Dunlop HM, Pushkaran B,
Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J,
Wainscoat JS, et al: Detection of elevated levels of
tumour-associated microRNAs in serum of patients with diffuse large
B-cell lymphoma. Br J Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Heneghan HM, Miller N, Lowery AJ, Sweeney
KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally
invasive biomarkers for breast cancer. Ann Surg. 251:499–505. 2010.
View Article : Google Scholar : PubMed/NCBI
|
